| Value | ₹7.98 Cr |
|---|
BSE filing, NSE: ADVENZYMES. Summary written from the filing by ALFA Finder's alert engine.
Advanced Enzyme Technologies Ltd: key numbers
- Share price
- ₹259.75
- Market cap
- ₹2,909 Cr
- Revenue (annual)
- ₹745.8 Cr
- Net profit (annual)
- ₹168.7 Cr
- P/E (TTM)
- 17.5×Sector 46.1×
- Promoter holding
- 43.56%+0.32% QoQ
- FII holding
- 26.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Advanced Enzyme Technologies Ltd
All →Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme bought back 64,583 shares on 28-10-2026 at an average ₹262.49, totalling 23,56,451 shares to date. Purchases were made via Emkay Global on the open market.
- Value
- ₹1.70 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme bought back 29,115 shares on October 27, 2026, worth about ₹0.75 Crore. Cumulative buyback stands at 22,91,868 shares under its open-market programme.
- Value
- ₹0.75 Cr
Advanced Enzyme Technologies Board Meeting Date
Advanced Enzyme Technologies will hold a board meeting on 31 October 2026 to approve Q2 and H1 FY27 unaudited results. The trading window stays closed until 2 November 2026.
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies bought back 58,326 equity shares at an average price of ₹263.3605 per share on October 22, 2026.
- Value
- ₹1.54 Cr
Advanced Enzyme Technologies Promoter Reclassification
Advanced Enzyme Technologies Ltd. received a request from Snehal Shamsunder Soni to reclassify their shareholding from the 'Promoter Group' to the 'Public' category.
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies reported the daily buyback of 55,794 shares from the open market at an average price of Rs. 267.5974 per share.
- Value
- ₹1.49 Cr
Other merger & restructuring announcements
All →Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr
Vraj Iron & Steel Merger & Restructuring Worth ₹4.55 Cr
Vraj Iron and Steel transferred 396,000 MVK Industries shares to promoter Gopal Sponge for Rs 4.55 Crore. The sale was completed on October 28, 2026.
- Value
- ₹4.55 Cr